Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.
 Back to Profile

Christopher Wardell

Concepts (266)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Multiple Myeloma
39
2025
3049
1.980
 Why?
Mutation
21
2022
1347
1.680
 Why?
High-Throughput Nucleotide Sequencing
5
2021
182
0.980
 Why?
Translocation, Genetic
14
2021
265
0.950
 Why?
Whole Body Imaging
1
2025
26
0.940
 Why?
Radiographic Image Interpretation, Computer-Assisted
1
2025
42
0.920
 Why?
Image Processing, Computer-Assisted
1
2025
253
0.830
 Why?
Oncogenes
2
2018
60
0.710
 Why?
Bone and Bones
1
2025
494
0.710
 Why?
Tomography, X-Ray Computed
1
2025
1165
0.630
 Why?
Biliary Tract Neoplasms
1
2018
6
0.580
 Why?
Cholangiocarcinoma
1
2018
25
0.570
 Why?
Gene Expression Profiling
14
2022
1105
0.570
 Why?
Genomics
8
2022
268
0.540
 Why?
Proto-Oncogene Proteins B-raf
3
2022
81
0.510
 Why?
Gene Expression Regulation, Neoplastic
11
2022
857
0.500
 Why?
Prognosis
15
2021
2099
0.410
 Why?
Brain Neoplasms
3
2023
291
0.390
 Why?
Gene Dosage
5
2020
78
0.380
 Why?
Antineoplastic Combined Chemotherapy Protocols
6
2020
1031
0.380
 Why?
Humans
52
2025
52483
0.370
 Why?
Genetic Predisposition to Disease
5
2018
528
0.370
 Why?
Plasma Cells
4
2021
239
0.360
 Why?
Genome, Human
4
2021
121
0.350
 Why?
Evolution, Molecular
2
2021
93
0.350
 Why?
Liver Neoplasms
3
2022
333
0.340
 Why?
DNA Mutational Analysis
7
2020
180
0.330
 Why?
Thalidomide
5
2019
377
0.320
 Why?
DNA Copy Number Variations
4
2021
117
0.320
 Why?
In Situ Hybridization, Fluorescence
11
2023
263
0.310
 Why?
Software
2
2021
280
0.290
 Why?
Monoclonal Gammopathy of Undetermined Significance
4
2017
125
0.290
 Why?
Neoplasm Recurrence, Local
3
2021
649
0.270
 Why?
Aged
16
2025
10121
0.270
 Why?
Chromosome Aberrations
6
2022
297
0.270
 Why?
Carcinoma, Hepatocellular
2
2022
202
0.270
 Why?
Middle Aged
18
2025
13028
0.260
 Why?
Polymorphism, Single Nucleotide
3
2018
505
0.260
 Why?
Male
26
2025
26761
0.260
 Why?
Female
27
2025
28171
0.250
 Why?
Clonal Evolution
2
2019
58
0.240
 Why?
Epigenesis, Genetic
4
2018
406
0.240
 Why?
Chromosomes, Human, Pair 1
2
2019
96
0.240
 Why?
Immunoglobulin Heavy Chains
3
2014
46
0.240
 Why?
Neoplasm Proteins
3
2017
334
0.230
 Why?
Disease Progression
8
2021
871
0.220
 Why?
Gene Regulatory Networks
2
2022
111
0.220
 Why?
Lymphoma, B-Cell, Marginal Zone
1
2023
24
0.210
 Why?
Polycomb Repressive Complex 2
2
2021
48
0.200
 Why?
Chromosomes, Human, Pair 14
5
2014
75
0.200
 Why?
Central Nervous System Neoplasms
1
2023
68
0.200
 Why?
Exome
4
2017
55
0.200
 Why?
STAT2 Transcription Factor
1
2021
6
0.190
 Why?
STAT1 Transcription Factor
1
2021
27
0.190
 Why?
Germ-Line Mutation
2
2021
66
0.190
 Why?
Li-Fraumeni Syndrome
1
2021
12
0.190
 Why?
Hematologic Neoplasms
1
2023
106
0.190
 Why?
Genome-Wide Association Study
3
2018
186
0.180
 Why?
Japan
2
2018
38
0.180
 Why?
Gene Frequency
2
2017
98
0.170
 Why?
Aged, 80 and over
9
2021
3392
0.170
 Why?
Cell Cycle
1
2021
230
0.170
 Why?
Glioblastoma
1
2021
97
0.170
 Why?
Exosome Multienzyme Ribonuclease Complex
1
2020
12
0.170
 Why?
Neoplasms
2
2020
1325
0.170
 Why?
Leukemia, Plasma Cell
1
2020
33
0.170
 Why?
Ecosystem
1
2021
96
0.160
 Why?
DNA Methylation
3
2016
592
0.160
 Why?
Chromosomal Instability
1
2019
16
0.160
 Why?
Genes, myc
1
2019
39
0.160
 Why?
Chromosomes, Human, Pair 4
3
2014
30
0.150
 Why?
Diploidy
2
2017
25
0.150
 Why?
Cell Survival
2
2018
612
0.150
 Why?
Chromosomes, Human, Pair 11
3
2014
55
0.150
 Why?
INDEL Mutation
1
2018
4
0.150
 Why?
Genes, Tumor Suppressor
2
2021
74
0.150
 Why?
Mutagenesis
1
2018
61
0.150
 Why?
Italy
1
2018
26
0.150
 Why?
Genes, Immunoglobulin Heavy Chain
2
2019
13
0.150
 Why?
Adult
13
2021
14161
0.140
 Why?
Transcriptional Elongation Factors
1
2017
17
0.140
 Why?
Chromosomes, Human, Pair 5
1
2017
17
0.140
 Why?
Histone-Lysine N-Methyltransferase
2
2016
55
0.140
 Why?
Enhancer Elements, Genetic
1
2017
58
0.140
 Why?
Reproducibility of Results
1
2021
1229
0.140
 Why?
Transcriptome
4
2021
370
0.140
 Why?
Chromosomes, Human
1
2017
41
0.140
 Why?
Melanoma
1
2020
288
0.130
 Why?
Hepatocytes
1
2018
190
0.130
 Why?
Immunologic Factors
1
2017
117
0.130
 Why?
B-Lymphocytes
2
2016
184
0.130
 Why?
Neoplasms, Multiple Primary
1
2016
44
0.130
 Why?
Neoplasm Metastasis
1
2016
243
0.120
 Why?
Melphalan
2
2013
181
0.120
 Why?
Oligodendroglioma
1
2015
6
0.120
 Why?
Sequence Analysis, DNA
2
2016
229
0.120
 Why?
Endoribonucleases
1
2015
17
0.120
 Why?
ras Proteins
1
2015
64
0.120
 Why?
Skin Neoplasms
1
2020
505
0.120
 Why?
Survival Rate
4
2020
945
0.120
 Why?
Basic Helix-Loop-Helix Transcription Factors
1
2015
44
0.120
 Why?
Endoplasmic Reticulum Stress
1
2015
50
0.120
 Why?
Survival Analysis
5
2015
673
0.110
 Why?
SMN Complex Proteins
1
2014
4
0.110
 Why?
RNA Processing, Post-Transcriptional
1
2014
24
0.110
 Why?
Signal Transduction
5
2022
1671
0.110
 Why?
Mutation Rate
3
2021
36
0.110
 Why?
Cyclin D
1
2013
18
0.110
 Why?
Chromosome Deletion
2
2011
142
0.110
 Why?
Transcription Factors
2
2015
566
0.110
 Why?
Kaplan-Meier Estimate
4
2018
483
0.110
 Why?
Genes, erbB-1
1
2013
9
0.110
 Why?
Nerve Tissue Proteins
1
2015
187
0.100
 Why?
RNA, Neoplasm
1
2013
45
0.100
 Why?
Cell Line, Tumor
4
2022
1470
0.100
 Why?
Chromosome Breakage
1
2013
16
0.100
 Why?
Precursor Cells, B-Lymphoid
1
2013
8
0.100
 Why?
Repressor Proteins
1
2014
155
0.100
 Why?
Germinal Center
1
2013
30
0.100
 Why?
RNA Splicing
3
2021
41
0.100
 Why?
Retrospective Studies
1
2025
6607
0.100
 Why?
Genetic Heterogeneity
1
2012
20
0.100
 Why?
DNA-Binding Proteins
1
2015
422
0.100
 Why?
Cell Transformation, Neoplastic
1
2013
184
0.100
 Why?
Acetyltransferases
1
2011
19
0.090
 Why?
Cyclin-Dependent Kinase Inhibitor p18
1
2011
27
0.090
 Why?
Chromosomes, Human, Pair 17
1
2011
35
0.090
 Why?
RNA, Messenger
1
2015
1132
0.090
 Why?
Antineoplastic Agents
3
2018
1222
0.090
 Why?
DNA, Neoplasm
3
2018
146
0.090
 Why?
Cell Proliferation
3
2022
1023
0.090
 Why?
Multivariate Analysis
3
2021
591
0.090
 Why?
TOR Serine-Threonine Kinases
1
2010
80
0.080
 Why?
Remission Induction
2
2021
218
0.080
 Why?
Phenotype
3
2022
789
0.080
 Why?
Clone Cells
2
2021
77
0.080
 Why?
Tumor Suppressor Protein p53
1
2011
221
0.080
 Why?
MicroRNAs
1
2013
387
0.080
 Why?
DNA
1
2012
549
0.080
 Why?
Alleles
2
2021
276
0.070
 Why?
Transcriptional Activation
2
2021
122
0.070
 Why?
Spliceosomes
2
2021
10
0.070
 Why?
Follow-Up Studies
3
2020
2279
0.070
 Why?
Genomic Instability
2
2018
89
0.070
 Why?
Epigenomics
2
2017
75
0.070
 Why?
Risk Factors
3
2021
3889
0.060
 Why?
Loss of Heterozygosity
2
2018
78
0.060
 Why?
Disease-Free Survival
2
2019
460
0.060
 Why?
Treatment Outcome
4
2019
5422
0.060
 Why?
Chromosomes, Human, Pair 20
2
2014
11
0.060
 Why?
Protein Binding
2
2017
667
0.060
 Why?
Liver
2
2022
1156
0.050
 Why?
Genotype
2
2017
566
0.050
 Why?
Dexamethasone
2
2019
438
0.050
 Why?
Histones
2
2016
314
0.050
 Why?
Proportional Hazards Models
2
2015
443
0.050
 Why?
Janus Kinase 1
1
2021
16
0.050
 Why?
Janus Kinase 2
1
2021
25
0.050
 Why?
Nitriles
1
2021
53
0.050
 Why?
Gene Rearrangement
1
2022
75
0.050
 Why?
Organoids
1
2021
39
0.050
 Why?
Syndecan-1
1
2021
74
0.050
 Why?
Microarray Analysis
2
2012
71
0.050
 Why?
Biomarkers, Pharmacological
2
2011
26
0.050
 Why?
Chromosome Mapping
2
2011
154
0.050
 Why?
Polymerase Chain Reaction
2
2013
461
0.050
 Why?
Cell Line
2
2015
1030
0.040
 Why?
Cell Movement
1
2022
268
0.040
 Why?
Pyrazoles
1
2021
114
0.040
 Why?
Proto-Oncogene Proteins p21(ras)
1
2021
69
0.040
 Why?
Alternative Splicing
1
2021
62
0.040
 Why?
Gene Expression Regulation, Leukemic
1
2020
32
0.040
 Why?
Pyrimidines
1
2021
199
0.040
 Why?
Phosphoproteins
1
2021
119
0.040
 Why?
Gene Expression
2
2013
618
0.040
 Why?
Lymphoma, Follicular
1
2020
27
0.040
 Why?
Prospective Studies
2
2016
2481
0.040
 Why?
Protein Disulfide-Isomerases
1
2019
14
0.040
 Why?
Recurrence
1
2021
672
0.040
 Why?
Young Adult
2
2021
4329
0.040
 Why?
Maintenance Chemotherapy
1
2019
51
0.040
 Why?
Syndrome
1
2019
247
0.040
 Why?
Transcription Elongation, Genetic
1
2017
4
0.040
 Why?
Physical Chromosome Mapping
1
2017
8
0.040
 Why?
Genetic Drift
1
2017
3
0.040
 Why?
Gene Knockdown Techniques
1
2018
108
0.040
 Why?
Caspases
1
2018
104
0.030
 Why?
Unfolded Protein Response
1
2017
32
0.030
 Why?
Genetic Loci
1
2017
49
0.030
 Why?
Xenograft Model Antitumor Assays
1
2018
220
0.030
 Why?
Mitosis
1
2017
88
0.030
 Why?
Molecular Targeted Therapy
1
2018
133
0.030
 Why?
Genetic Association Studies
1
2017
122
0.030
 Why?
Genetic Structures
1
2016
1
0.030
 Why?
Comparative Genomic Hybridization
1
2016
39
0.030
 Why?
Virus Integration
1
2016
9
0.030
 Why?
Risk
1
2017
316
0.030
 Why?
Regulatory Sequences, Nucleic Acid
1
2016
42
0.030
 Why?
Computational Biology
1
2018
212
0.030
 Why?
Algorithms
1
2020
672
0.030
 Why?
Nuclear Proteins
1
2017
245
0.030
 Why?
Immunosuppressive Agents
1
2017
243
0.030
 Why?
Tumor Microenvironment
1
2017
256
0.030
 Why?
Minor Histocompatibility Antigens
1
2015
18
0.030
 Why?
MafB Transcription Factor
1
2015
9
0.030
 Why?
Proto-Oncogene Proteins c-maf
1
2015
19
0.030
 Why?
Cytidine Deaminase
1
2015
12
0.030
 Why?
Antibodies, Monoclonal
1
2019
481
0.030
 Why?
RNA Stability
1
2015
25
0.030
 Why?
Patient Selection
1
2016
259
0.030
 Why?
Amino Acid Sequence
1
2016
578
0.030
 Why?
Chromosomes, Human, Pair 16
1
2014
18
0.030
 Why?
Proto-Oncogene Proteins c-myc
1
2015
53
0.030
 Why?
Multiplex Polymerase Chain Reaction
1
2014
13
0.030
 Why?
Cytogenetic Analysis
1
2014
80
0.030
 Why?
Ribonucleoproteins, Small Nuclear
1
2014
5
0.030
 Why?
Flow Cytometry
1
2017
478
0.030
 Why?
Time Factors
1
2021
2968
0.030
 Why?
Introns
1
2014
53
0.030
 Why?
Methylation
1
2014
126
0.030
 Why?
Single-Cell Analysis
1
2014
81
0.030
 Why?
Protein Isoforms
1
2014
123
0.030
 Why?
Base Sequence
1
2015
640
0.030
 Why?
Down-Regulation
1
2015
346
0.030
 Why?
High-Throughput Screening Assays
1
2013
38
0.030
 Why?
Protein Structure, Tertiary
1
2014
242
0.030
 Why?
Molecular Sequence Data
1
2015
778
0.030
 Why?
HeLa Cells
1
2014
265
0.030
 Why?
Osteonectin
1
2013
10
0.030
 Why?
Chromosomes, Human, Pair 7
1
2013
30
0.030
 Why?
Karyotyping
1
2013
78
0.030
 Why?
Azacitidine
1
2013
39
0.030
 Why?
Transforming Growth Factor beta1
1
2013
62
0.030
 Why?
Mass Spectrometry
1
2014
292
0.030
 Why?
Homologous Recombination
1
2013
41
0.030
 Why?
Early Detection of Cancer
1
2014
189
0.020
 Why?
Disease Models, Animal
1
2018
1478
0.020
 Why?
Validation Studies as Topic
1
2012
10
0.020
 Why?
Tumor Suppressor Proteins
1
2013
130
0.020
 Why?
Apoptosis
1
2018
1119
0.020
 Why?
Gene Library
1
2012
44
0.020
 Why?
Laboratories
1
2012
21
0.020
 Why?
Hemizygote
1
2011
6
0.020
 Why?
Predictive Value of Tests
1
2014
944
0.020
 Why?
Drug Resistance, Neoplasm
1
2013
326
0.020
 Why?
Animals
2
2018
13505
0.020
 Why?
Bone Marrow
1
2013
364
0.020
 Why?
Breast Neoplasms
1
2020
1212
0.020
 Why?
Vincristine
1
2010
88
0.020
 Why?
Prednisolone
1
2010
56
0.020
 Why?
Oligonucleotide Array Sequence Analysis
1
2011
405
0.020
 Why?
Cluster Analysis
1
2010
233
0.020
 Why?
Precancerous Conditions
1
2010
85
0.020
 Why?
Adolescent
1
2021
6739
0.020
 Why?
Cyclophosphamide
1
2010
171
0.020
 Why?
Intracellular Signaling Peptides and Proteins
1
2010
134
0.020
 Why?
Clinical Trials as Topic
1
2012
467
0.020
 Why?
Stem Cell Transplantation
1
2010
185
0.020
 Why?
Child
1
2021
7248
0.020
 Why?
Models, Biological
1
2012
735
0.020
 Why?
Doxorubicin
1
2010
241
0.020
 Why?
Sex Factors
1
2011
727
0.020
 Why?
Up-Regulation
1
2010
454
0.020
 Why?
Risk Assessment
1
2013
1327
0.020
 Why?
Prevalence
1
2011
1006
0.020
 Why?
Mice
1
2018
5949
0.020
 Why?
Wardell's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (266) concept(s)
_
Co-Authors Expand Description
See all (32) people
_
Similar People Expand Description
See all (34) people
_
Same Department Expand Description
Search Department